ohm: You're wrong my friend. Even if a lawsuit against the FDA survived a motion to dismiss based on sovereign immunity/discretionary authority, it would take years to reach trial. Any deposition testimony or motion practice assertions would be easily deflected as mere allegations. And the FDA would certainly be appreciative to CYDY management for commencing a fraud based lawsuit against the agency, and ensure fair treatment on future discretionary decisions. The chances of an FDA employee being punished, let alone dismissed, would be beyond reasonable calculation.

If you are correct that the hold extends to all new clinical trial protocol requests. and Dr Recknor's apparent failure to file a trial protocol over the last several months is consistent with that narrative, than management is burying its head in the sand, in my opinion, if it refuses to consider the ramifications of a prolonged stall job by the FDA regarding future trials.